Aprepitant: a novel antiemetic for chemotherapy-induced nausea and vomiting.
about
Update and new trends in antiemetic therapy: the continuing need for novel therapies.CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.Aprepitant: the evidence for its place in the prevention of chemotherapy-induced nausea and vomiting.Prospective pharmacologic therapies for the overactive bladderTreatment of Chemotherapy-Induced Nausea in Cancer Patients.Comparative evaluation of triplet antiemetic schedule versus doublet antiemetic schedule in chemotherapy-induced emesis in head and neck cancer patients.Frontiers in functional dyspepsia.Recent advances in pharmacotherapy of chemotherapy-induced nausea and vomiting.Antiemetic therapy options for chemotherapy-induced nausea and vomiting in breast cancer patients.Neuromodulatory processes of the brain-gut axis.Anticipatory nausea in animal models: a review of potential novel therapeutic treatments.The use of a rapid MS-based method for the quantification of the CYP 3A4 protein directly from hepatocyte cell lysate for CYP induction studies.Effect of aprepitant on intravenous tacrolimus disposition in reduced intensity hematopoietic stem cell transplantation.Phase II study of palonosetron, aprepitant and dexamethasone to prevent nausea and vomiting induced by multiple-day emetogenic chemotherapy.
P2860
Q34143667-23C9CC2C-879D-4E68-9624-D2D3FC2C702DQ34437996-E51FADCD-F365-4E78-A14A-7A1FD9BC68BFQ34450534-F24B6548-B182-451B-B209-033602789136Q35076367-4B8B2353-2AC4-4D5D-B18D-3F58039A5E52Q35282520-28DE4869-008F-4326-B58B-3B76B8DF4309Q36093627-7508EEFF-8923-4570-ADEF-5F1C8E70283FQ36206694-56D8E65F-6681-42E0-8105-636E6ACA4ACCQ36575446-35092854-1DEC-4DDB-985C-9E70A7F10138Q37355479-E44F1B84-FE01-475D-8517-B2FB1235B082Q37390659-DCDC23D2-8299-4600-AF7C-59EE21C6C046Q38208999-3F0DC72E-6532-47AC-B646-F6700595629AQ41656544-9F52D39D-21FA-472F-A434-C3235055D1AFQ45169488-43C06A69-D000-4745-AE23-5EB3F2A023B8Q49937793-FF5924F8-FC5F-41ED-AC32-8447FCAD9ADF
P2860
Aprepitant: a novel antiemetic for chemotherapy-induced nausea and vomiting.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Aprepitant: a novel antiemetic for chemotherapy-induced nausea and vomiting.
@ast
Aprepitant: a novel antiemetic for chemotherapy-induced nausea and vomiting.
@en
type
label
Aprepitant: a novel antiemetic for chemotherapy-induced nausea and vomiting.
@ast
Aprepitant: a novel antiemetic for chemotherapy-induced nausea and vomiting.
@en
prefLabel
Aprepitant: a novel antiemetic for chemotherapy-induced nausea and vomiting.
@ast
Aprepitant: a novel antiemetic for chemotherapy-induced nausea and vomiting.
@en
P2860
P356
P1476
Aprepitant: a novel antiemetic for chemotherapy-induced nausea and vomiting.
@en
P2093
Alison M Massaro
Kristi L Lenz
P2860
P356
10.1345/APH.1E242
P407
P577
2004-11-23T00:00:00Z